Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016

Antibiotics

Volumn 6, Issue 3, 2017, Pages

  Gandra, Sumanth ^a   Singh, Sanjeev K ^b   Jinka, Dasaratha R ^c   Kanithi, Ravishankar ^d   Chikkappa, Ashok K ^e   Sharma, Anita ^f   Dharmapalan, Dhanya ^g   Vasudevan, Anil Kumar ^b   Tunga, Onkaraiah ^e   Akula, Akhila ^d   Garg, Garima ^f   Hsia, Yingfen ^h   Murki, Srinivas ⁱ   Alvarez Uria, Gerardo ^c   Sharland, Mike ^h   Laxminarayan, Ramanan ^a,j  

^a Center for Disease Dynamics Economics and Policy   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Rural Development Trust Hospital   (India)

^d Sowmya Children s Hospital   (India)

^e Rural Development Trust Hospital   (India)

^f FORTIS HOSPITAL   (India)

^g St Georges University ^*  (India)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ Andhra Pradesh India   (India)

^j PRINCETON UNIVERSITY   (United States)

more..

Author keywords

Antimicrobial use; Children; Hospital; India; Point prevalence survey

Indexed keywords

EID: 85030976847     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics6030019     Document Type: Article

References (24)

1. Laxminarayan, R.; Matsoso, P.; Pant, S.; Brower, C.; Rottingen, J.A.; Klugman, K.; Davies, S. Access to effective antimicrobials: A worldwide challenge. Lancet 2016, 387, 168-175. [CrossRef]
2. Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A.K.; Wertheim, H.F.; Sumpradit, N.; Vlieghe, E.; Hara, G.L.; Gould, I.M.; Goossens, H. et al. Antibiotic resistance: The need for global solutions. Lancet Infect. Dis. 2013, 13, 1057-1098. [CrossRef]
3. Gandra, S.; Mojica, N.; Klein, E.Y.; Ashok, A.; Nerurkar, V.; Kumari, M.; Ramesh, U.; Dey, S.; Vadwai, V.; Das, B.R. et al. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. Int. J. Infect. Dis. 2016, 50, 75-82. [CrossRef] [PubMed]
4. Gelband, H.; Miller-Petrie, M.; Pant, S.; Gandra, S.; Levinson, J.; Barter, D.; White, A.; Laxminarayan, R. The State of the World’s Antibiotics, 2015; Center for Disease Dynamics, Economics & Policy: New Delhi, India, 2015.
5. World Health Organisation (WHO). WHO’s First Global Report on Antibiotic Resistance Reveals Serious, Worldwide Threat to Public Health. Available online: http://www.who.int/mediacentre/news/releases/2014/amr-report/en/ (accessed on 18 March 2017).
6. Skoog, G.; Struwe, J.; Cars, O.; Hanberger, H.; Odenholt, I.; Prag, M.; Skarlund, K.; Ulleryd, P.; Erntell, M. Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: Data for actions 2003-2010. Euro. Surveill. 2016, 21. [CrossRef] [PubMed]
7. Sanjeev Singh, T.J.; Versporten, A.; Sengupta, S.; Fini, P.; Sharland, M.; Kumar, K.R.; Goossens, H. A point prevalence surveillance study from pediatric and neonatal specialty hospitals in India. J. Pediatr. Infect. Dis. 2014, 9, 151-155.
8. Versporten, A.; Bielicki, J.; Drapier, N.; Sharland, M.; Goossens, H. The worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children. J. Antimicrob. Chemother. 2016, 71, 1106-1117. [CrossRef] [PubMed]
9. Ceyhan, M.; Yildirim, I.; Ecevit, C.; Aydogan, A.; Ornek, A.; Salman, N.; Somer, A.; Hatipoglu, N.; Camcioglu, Y.; Alhan, E. et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: A multicenter point prevalence survey. Int. J. Infect. Dis. 2010, 14, e55-e61. [CrossRef] [PubMed]
10. De Luca, M.; Dona, D.; Montagnani, C.; Lo Vecchio, A.; Romanengo, M.; Tagliabue, C.; Centenari, C.; D’Argenio, P.; Lundin, R.; Giaquinto, C. et al. Antibiotic prescriptions and prophylaxis in Italian children: Is it time to change? Data from the ARPEC project. PLoS ONE 2016, 11, e0154662. [CrossRef] [PubMed]
11. Osowicki, J.; Gwee, A.; Noronha, J.; Palasanthiran, P.; McMullan, B.; Britton, P.N.; Isaacs, D.; Lai, T.; Nourse, C.; Avent, M. et al. Australia-wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital. Med. J. Aust. 2014, 201, 657-662. [CrossRef] [PubMed]
12. Gharbi, M.; Doerholt, K.; Vergnano, S.; Bielicki, J.A.; Paulus, S.; Menson, E.; Riordan, A.; Lyall, H.; Patel, S.V.; Bernatoniene, J. et al. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ Open 2016, 6, e012675. [CrossRef] [PubMed]
13. Sviestina, I.; Mozgis, D. Antimicrobial usage among hospitalized children in Latvia: A neonatal and pediatric antimicrobial point prevalence survey. Medicina 2014, 50, 175-181. [CrossRef] [PubMed]
14. Pakyz, A.L.; Gurgle, H.E.; Ibrahim, O.M.; Oinonen, M.J.; Polk, R.E. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect. Control Hosp. Epidemiol. 2009, 30, 600-603. [CrossRef] [PubMed]
15. Fahimzad, A.; Eydian, Z.; Karimi, A.; Shiva, F.; Sayyahfar, S.; Kahbazi, M.; Rahbarimanesh, A.; Sedighi, I.; Arjmand, R.; Soleimani, G. et al. Surveillance of antibiotic consumption point prevalence survey 2014: Antimicrobial prescribing in pediatrics wards of 16 Iranian hospitals. Arch. Iran. Med. 2016, 19, 204-209. [PubMed]
16. Xie, D.S.; Xiang, L.L.; Li, R.; Hu, Q.; Luo, Q.Q.; Xiong, W. A multicenter point-prevalence survey of antibiotic use in 13 Chinese hospitals. J. Infect. Public Health 2015, 8, 55-61. [CrossRef] [PubMed]
17. Sharma, M.; Damlin, A.; Pathak, A.; Stalsby Lundborg, C. Antibiotic prescribing among pediatric inpatients with potential infections in two private sector hospitals in Central India. PLoS ONE 2015, 10, e0142317. [CrossRef] [PubMed]
18. National Center for Disease Control. National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. 2016. Available online: http://pbhealth.gov.in/amr_guideline7001495889.Pdf (accessed on 26 January 2017).
19. Arora, N.K.; Awasthi, S.; Gupta, P.; Kabra, S.K.; Mathew, J.L.; Nedunchelian, K.; Niswade, A.K.; Patel, A.; Rewal, S.; Sethi, G.R. et al. Rational use of antibiotics for pneumonia. Indian Pediatr. 2010, 47, 11-18. [CrossRef]
20. Torumkuney, D.; Chaiwarith, R.; Reechaipichitkul, W.; Malatham, K.; Chareonphaibul, V.; Rodrigues, C.; Chitkins, D.S.; Dias, M.; Anandan, S.; Kanakapura, S. et al. Results from the survey of antibiotic resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore. J. Antimicrob. Chemother. 2016, 71, 3628. [CrossRef] [PubMed]
21. Bratzler, D.W.; Dellinger, E.P.; Olsen, K.M.; Perl, T.M.; Auwaerter, P.G.; Bolon, M.K.; Fish, D.N.; Napolitano, L.M.; Sawyer, R.G.; Slain, D. et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg. Infect. 2013, 14, 73-156. [CrossRef] [PubMed]
22. Resistancemap. Center for Disease Dynamics, Economics & Policy. Available online: https://resistancemap.cddep.org/resmap/resistance/ (accessed on 24 September 2015).
23. Hu, F.P.; Guo, Y.; Zhu, D.M.; Wang, F.; Jiang, X.F.; Xu, Y.C.; Zhang, X.J.; Zhang, C.X.; Ji, P.; Xie, Y. et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin. Microbiol. Infect. 2016, 22, S9-S14. [CrossRef] [PubMed]
24. Paterson, D.L.; Bonomo, R.A. Extended-spectrum beta-lactamases: A clinical update. Clin. Microbiol. Rev. 2005, 18, 657-686. [CrossRef] [PubMed]